COMP <GO>
COO vs MRK // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
The Cooper Companies Inc. (NASDAQ) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: COO 5
— MRK 10
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: MRK
LAST: $59.55 (-1.31%) • MKT CAP: $11.47B
options-implied-move
6.90%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
options-implied-move
6.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (COO VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | COO | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 65.50% | 74.80% | -9.30 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.30% | 20.70% | -15.40 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.3x | 15.3x | -2.00 | COO | /valuation <GO> |
| Free Cash Flow Yield | 3.78% | 3.42% | +0.36 | COO | /fcf-yield <GO> |
| Operating Margin | 16.70% | 34.30% | -17.60 | MRK | /operating-margins <GO> |
| Net Profit Margin | 9.20% | 28.10% | -18.90 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 5.10% | 1.30% | +3.80 | COO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.13 | 5.19 | -2.06 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | COO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.90% | 6.60% | +0.30 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.5 | 56.9 | -4.34 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 0.92 | +0.09 | COO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.5x | 18.4x | +10.10 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.47B | $361.02B | -$349.55B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | COO REV | MRK REV | COO GROSS % | MRK GROSS % | COO FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.09B | $65.01B | 65.5% | 74.8% | $433.7M | $12.36B |
| FY 2024 | $3.90B | $64.17B | 66.6% | 76.3% | $288.1M | $18.10B |
| FY 2023 | $3.59B | $60.12B | 44.0% | 44.0% | $445.8M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
COO // BETA 1.01
MRK // BETA 0.92